Price:
Rs. 2,120.00
Sample Type: EXTRA PULMONARY
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What is the AFB MDR Screen by Hain LPA, Extra Pulmonary Test?
This test uses the Hain Line Probe Assay to detect Mycobacterium tuberculosis DNA and mutations associated with resistance to rifampicin and isoniazid in extrapulmonary samples.
Why is this test important?
It helps identify multidrug-resistant TB (MDR-TB) in extrapulmonary sites, allowing early modification of treatment regimens and improving patient outcomes.
Who should undergo this test?
Patients with suspected extrapulmonary TB or those not responding to standard TB treatment are advised to undergo this test.
How is the test performed?
DNA is extracted from the extrapulmonary sample and analyzed using the Hain Line Probe Assay at Metropolis Healthcare to identify drug-resistance mutations.
What do the results indicate?
Results indicate whether the Mycobacterium tuberculosis strain is resistant or sensitive to rifampicin and isoniazid, guiding effective treatment planning.
Are there any risks associated with the test?
The test is safe, with only minimal procedural risk associated with extrapulmonary sample collection.
Why choose Metropolis Healthcare for this test?
Metropolis Healthcare provides rapid, accurate, and reliable MDR-TB detection using advanced Hain LPA technology with expert molecular analysis for precise and effective patient management.